ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

16 links0 made here, not in the record14 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06390319Adding Dasatinib OrVenetoclax To ImproveResponses In Children WithNewly Diagnosed T-CellAcute LymphoblasticLeukemia (ALL) Or Lymphoma(T-LLY) Or Mixed PhenotypeSt. Jude Children's Research HPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSPrecursor T-Cell Lymphoblas…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionLymphoma, T-CellThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Leukemia, Biphenotypic, Acu…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSDexamethasoneIntervention entry›As of now · Rule based · BackgroundBackgroundVincristineIntervention entry›As of now · Rule based · BackgroundBackgroundDaunorubicinIntervention entry›As of now · Rule based · BackgroundBackgroundCalaspargase pegolIntervention entry›As of now · Rule based · BackgroundBackgroundDasatinibIntervention entry›As of now · Rule based · TestedTestedVenetoclaxIntervention entry›As of now · Rule based · TestedTestedBortezomibIntervention entry›As of now · Rule based · TestedTestedCyclophosphamideIntervention entry›As of now · Rule based · BackgroundBackgroundCytarabineIntervention entry›As of now · Rule based · BackgroundBackgroundMercaptopurineIntervention entry›As of now · Rule based · BackgroundBackgroundNelarabineIntervention entry›As of now · Rule based · TestedTestedMethotrexateIntervention entry›As of now · Rule based · BackgroundBackgroundThioguanineIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
As of nowPrecursor T-Cell Lymphoblastic Leukemia-LymphomaRule based · main-condition ruleMain conditionCurrent
As of nowDexamethasoneRule based · role ruleBackgroundCurrent
As of nowVincristineRule based · role ruleBackgroundCurrent
As of nowDaunorubicinRule based · role ruleBackgroundCurrent
As of nowCalaspargase pegolRule based · role ruleBackgroundCurrent
As of nowDasatinibRule based · role ruleTestedCurrent
As of nowVenetoclaxRule based · role ruleTestedCurrent
As of nowBortezomibRule based · role ruleTestedCurrent
As of nowCyclophosphamideRule based · role ruleBackgroundCurrent
As of nowCytarabineRule based · role ruleBackgroundCurrent
As of nowMercaptopurineRule based · role ruleBackgroundCurrent
As of nowNelarabineRule based · role ruleTestedCurrent
As of nowMethotrexateRule based · role ruleBackgroundCurrent
As of nowThioguanineRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.